The article describes the case of a 29-year-old Saudi Arabian male with known sickle cell disease. Topics discussed include the complex medical history of the patient, the discovery of hemoglobin D (HbD) in the patient, and how the laboratory challenges and potential clinical consequences of a hemoglobin variant transfusion could be avoided.